121 related articles for article (PubMed ID: 22685632)
1. Alternative splicing and cancer.
Auboeuf D; Carmo-Fonseca M; Valcarcel J; Biamonti G
J Nucleic Acids; 2012; 2012():363809. PubMed ID: 22685632
[No Abstract] [Full Text] [Related]
2. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.
Martínez-Montiel N; Anaya-Ruiz M; Pérez-Santos M; Martínez-Contreras RD
Genes (Basel); 2017 Oct; 8(10):. PubMed ID: 28981467
[TBL] [Abstract][Full Text] [Related]
3. Significance of alternative splicing in cancer cells.
Qi F; Li Y; Yang X; Wu YP; Lin LJ; Liu XM
Chin Med J (Engl); 2020 Jan; 133(2):221-228. PubMed ID: 31764175
[TBL] [Abstract][Full Text] [Related]
4. The Functional Impact of Alternative Splicing in Cancer.
Climente-González H; Porta-Pardo E; Godzik A; Eyras E
Cell Rep; 2017 Aug; 20(9):2215-2226. PubMed ID: 28854369
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing and its impact as a cancer diagnostic marker.
Kim YJ; Kim HS
Genomics Inform; 2012 Jun; 10(2):74-80. PubMed ID: 23105933
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of survival-associated alternative splicing events in gastric cancer.
Zhang S; Hu Z; Lan Y; Long J; Wang Y; Chen X; Xu X; Zeng Z; Ouyang Y
Aging (Albany NY); 2020 Nov; 12(21):21923-21941. PubMed ID: 33186122
[TBL] [Abstract][Full Text] [Related]
7. Identification of alternative splicing markers for breast cancer.
Venables JP; Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Koh C; Gervais-Bird J; Lapointe E; Froehlich U; Durand M; Gendron D; Brosseau JP; Thibault P; Lucier JF; Tremblay K; Prinos P; Wellinger RJ; Chabot B; Rancourt C; Elela SA
Cancer Res; 2008 Nov; 68(22):9525-31. PubMed ID: 19010929
[TBL] [Abstract][Full Text] [Related]
8. Profiling of prognostic alternative splicing in melanoma.
Ma FC; He RQ; Lin P; Zhong JC; Ma J; Yang H; Hu XH; Chen G
Oncol Lett; 2019 Aug; 18(2):1081-1088. PubMed ID: 31423168
[TBL] [Abstract][Full Text] [Related]
9. Alternative Splicing as a Target for Cancer Treatment.
Martinez-Montiel N; Rosas-Murrieta NH; Anaya Ruiz M; Monjaraz-Guzman E; Martinez-Contreras R
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439487
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures.
Cao ZX; Xiao GA; Zhang W; Ji J; Ye C; Liu D; Tian QQ; Prof YS
J Cancer; 2019; 10(22):5585-5596. PubMed ID: 31632503
[No Abstract] [Full Text] [Related]
11. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide identification of cancer-specific alternative splicing in circRNA.
Feng J; Chen K; Dong X; Xu X; Jin Y; Zhang X; Chen W; Han Y; Shao L; Gao Y; He C
Mol Cancer; 2019 Mar; 18(1):35. PubMed ID: 30849979
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
[TBL] [Abstract][Full Text] [Related]
15. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1.
Choksi A; Parulekar A; Pant R; Shah VK; Nimma R; Firmal P; Singh S; Kundu GC; Shukla S; Chattopadhyay S
Cancer Metab; 2021 Apr; 9(1):16. PubMed ID: 33863392
[TBL] [Abstract][Full Text] [Related]
18. Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer.
Zhu J; Chen Z; Yong L
Gynecol Oncol; 2018 Feb; 148(2):368-374. PubMed ID: 29191436
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing in lung cancer.
Pio R; Montuenga LM
J Thorac Oncol; 2009 Jun; 4(6):674-8. PubMed ID: 19461400
[TBL] [Abstract][Full Text] [Related]
20. The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.
Shilo A; Siegfried Z; Karni R
Mol Cell Oncol; 2015; 2(1):e970955. PubMed ID: 27308389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
